AD26 based therapeutic vaccines for HIV

Active Cooperative Agreement Awarded Last action

Award ID
U01AI145801
Recipient
Awarding agency
Obligated
$21,057,609

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date 92% complete
Originally
Funding
  • $19,553,346.00 Federal
  • $1,504,263.00 Non-federal
Place of performance
Boston, MA 02215, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $1,503,450 $0
Amendment $1,503,450 $0
Amendment -$925,781 $0
Amendment $925,781 $0
Amendment -$925,781 $0
Amendment $2,429,231 $0
Amendment $0 $0
Amendment $1,503,450 $0
Amendment $1,503,450 $0
Amendment $1,503,450 $0
Amendment $0 $0
Amendment $0 $0
Amendment $1,503,450 $0
Amendment $1,503,450 $0
Amendment $1,503,450 $0
Amendment $1,503,863 $0
Amendment $1,504,263 $0
Amendment AD26 based therapeutic vaccines for HIV - the goal of therapeutic vaccination is to increase host immune control of HIV-1 to achieve durable virologic control… $1,504,263 $1,504,263
Original award $1,509,907 $0
Show all 20

Subawards

Subrecipient Amount Awarded
Orlando Immunology Center, P.a. Clinical Trials $30,872
President And Fellows Of Harvard College Dr. Zheng will oversee the design of a phase I/II pilot clinical trial, provide input on data collection and CRF development, and provide support for scientific… $444,757

Quick answers

Who received award U01AI145801?

U01AI145801 was awarded to Beth Israel Deaconess Medical Center, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 12, 2020.

How much is award U01AI145801 worth?

$21,057,609 has been obligated on U01AI145801: $19,553,346 in federal funding and $1,504,263 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login